Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05124288
What this trial is testing

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Who this might be right for
Acute Myeloid Leukemia, in Relapse
Ciceri Fabio 500
Not applicableUnknownNCT01555359
What this trial is testing

Telomerase Activity as a Marker For Mobilization Quality

Who this might be right for
LymphomaMultiple Myeloma
Rabin Medical Center 50
Early research (Phase 1)Study completedNCT00561418
What this trial is testing

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 23
Very early researchStudy completedNCT00424242
What this trial is testing

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Northwestern University 15
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT05984199
What this trial is testing

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Leukemia, Myeloid, Acute
Vor Biopharma 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT06171906
What this trial is testing

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
MSC
ShiCang Yu 68
Testing effectiveness (Phase 2)Ended earlyNCT00074269
What this trial is testing

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Diego 5
Testing effectiveness (Phase 2)Study completedNCT02337595
What this trial is testing

Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteImmune Deficiency Disease+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Early research (Phase 1)Study completedNCT00288028
What this trial is testing

Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 15
Not applicableStudy completedNCT05943964
What this trial is testing

Virtual Rehabilitation in HCT

Who this might be right for
Hematopoietic Cell Transplant
Emory University 20
Not applicableStudy completedNCT01714570
What this trial is testing

Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

Who this might be right for
FebrileNeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 123
Testing effectiveness (Phase 2)Study completedNCT00803010
What this trial is testing

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 74
Testing effectiveness (Phase 2)Study completedNCT02876679
What this trial is testing

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

Who this might be right for
Graft vs Host Disease
Assistance Publique - Hôpitaux de Paris 94
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT06859424
What this trial is testing

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
AML (Acute Myelogenous Leukemia)Acute Lymphoid Leukemia (ALL)Acute Leukemia (Category)+8 more
Center for International Blood and Marrow Transplant Research 358
Testing effectiveness (Phase 2)Active Not RecruitingNCT02669251
What this trial is testing

Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host DiseaseBronchiolitis Obliterans Syndrome
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Not applicableNot Yet RecruitingNCT07141095
What this trial is testing

A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection

Who this might be right for
Infections, Cytomegalovirus
Institute of Hematology & Blood Diseases Hospital, China 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03475212
What this trial is testing

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionsAdenovirus InfectionEBV Infection
Pediatric Transplantation & Cellular Therapy Consortium 52
Next Page